AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Fresenius steps up restructuring at Kabi unit.(Brief Article)
M2 EUROPHARMA-(C)1999-2002 M2 COMMUNICATIONS LTD
German healthcare company Fresenius AG plans to step up restructuring at its nutrition and infusion therapy subsidiary, Fresenius Kabi.
The restructuring, which will cost an additional EUR25m in one-off charges this year, is expected to significantly improve profitability at Kabi next year.
The additional restructuring will focus on production at Fresenius Kabi's parenteral nutrition business, which supplies intravenous infusion products. Research and development activities …
-
- DAGENS INDUSTRI: A profile of Fresenius Kabi.
-
News wire article from: Chemical Business Newsbase
October 12, 2001
700+ words
-
- Fresenius Kabi buys Indian generics and API firm.(M&A)(Fresenius Kabi mergers...
-
Magazine article from: Chemical Week
Ramesh, Deepti
April 28, 2008
700+ words
-
- BUSINESS LINE: India: Fresenius Kabi in talks for new buys .
-
News wire article from: Business Line
March 25, 1999
700+ words
-
- Iodine deficiency associated with parenteral nutrition in extreme preterm...
-
Magazine article from: Archives of Disease in Childhood. Fetal and Neonatal Edition
Ibrahim, M. de Escobar, G. Morreale Visser, T.J. Duran, S. van Toor, H. Strachan, J. Williams, F.L.R. Hume, R.
January 1, 2003
700+ words
-
- Research and Markets: The future of parenteral nutrition: key players,...
-
News wire article from: Chemical Business Newsbase
November 26, 2010
700+ words
